The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C
<p>Abstract</p> <p>Background</p> <p>Non-organ-specific autoantibodies are found in a considerable number of anti-HCV positive patients. Previous studies investigated the clinical relevance of these antibodies in patients treated with interferon monotherapy, but not com...
Main Authors: | Matern Siegfried, Lorenzen Johann, Gartung Carsten, Dietrich Christoph G, Geier Andreas, Stolte Christian, Wasmuth Hermann E, Lammert Frank |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2334/4/4 |
Similar Items
-
Autoantibodies to Interferons in Infectious Diseases
by: Eugenia Quiros-Roldan, et al.
Published: (2023-05-01) -
Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study
by: Hui Li, et al.
Published: (2021-03-01) -
Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01) -
Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01) -
Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)